核苷酸市場規模、佔有率、趨勢分析報告：按產品、技術、應用、地區、細分市場預測，2025-2030 年

Nucleotide Market Size, Share & Trends Analysis Report By Product (Deoxy Nucleotides), By Technology (TaqMan Allelic Discrimination, Gene Chips & Microarrays), By Application, By Region, And Segment Forecasts, 2025 - 2030

出版日期: 2025年02月28日 | 出版商:

Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

簡介目錄圖表

核苷酸市場的成長和趨勢

根據Grand View Research, Inc.的最新報告，預計到2030年全球核苷酸市場規模將達到15.2億美元，2025年至2030年期間的複合年成長率為8.6%。

由於核苷酸在製藥和食品飲料行業的廣泛應用，預計全球核苷酸市場在預測期內將顯著成長。診斷研究和藥物應用佔據核苷酸市場主導地位，因為它具有增強免疫力、對腸道有正面作用以及對壓力恢復有正面影響等特性。此外，全球膳食核苷酸領域的研發不斷成長，加上用於牲畜營養的酵母衍生核苷酸，預計將在預測期內推動需求。

核苷酸市場報告重點

TaqMan 等位基因鑑別領域將在 2024 年佔據全球市場的主導地位，其次是透過焦磷酸測序的 SNP。
2024 年，診斷研究領域將主導全球核苷酸市場。
脫氧核苷酸 (dNTP) 部分將在全球核苷酸市場中佔據主導地位，到 2024 年其收益佔有率將達到 48.4%，並且很可能在預測期內以最快的複合年成長率擴張。
2024 年，北美將佔據最大的市場佔有率，達到 38.9%，而歐洲將在 2025 年至 2030 年期間以 8.4% 的複合年成長率快速擴張。

2024 年及 2030 年區域市場佔有率分析
區域市場儀表板
2018-2030年市場規模、預測趨勢分析
北美洲
- 美國
- 加拿大
- 墨西哥
歐洲
- 英國
- 德國
- 法國
- 義大利
- 西班牙
- 丹麥
- 瑞典
- 挪威
亞太地區
- 日本
- 中國
- 印度
- 澳洲
- 泰國
- 韓國
拉丁美洲
- 巴西
- 阿根廷
中東和非洲
- 南非
- 沙烏地阿拉伯
- 阿拉伯聯合大公國
- 科威特

第8章競爭格局

參與者概述
企業市場分析
公司分類
戰略地圖
公司簡介/上市公司
- CJ CheilJedang Corp.
- Star Lake Bioscience
- Thermo Fisher Scientific Inc.
- MEIHUA HOLDINGS GROUP CO., LTD.
- F. Hoffmann-La Roche Ltd.
- Biorigin
- DSM
- Promega Corporation
- Agilent Technologies, Inc.
- Lallemand Inc.
- Nanjing BIoTogether Co., Ltd.
- NuEra Nutraceuticals Inc.
- Ohly

簡介目錄圖表

Product Code: 978-1-68038-627-1

Nucleotide Market Growth & Trends:

The global nucleotide market size is expected to reach USD 1.52 billion by 2030, registering a CAGR of 8.6% from 2025 to 2030, according to a new report by Grand View Research, Inc. The global nucleotide market is expected to witness substantial growth over the forecast period owing to its widespread use in pharmaceuticals and food & beverage industries. Diagnostic research along with pharmaceutical applications dominated the nucleotide market owning to properties including enhanced immunity, positive effects on the intestines, and positive effects of recovery from stress. In addition, growing R&D in the field of dietary nucleotide coupled with yeast-derived nucleotide for livestock nutrition across the globe is expected to propel demand over the forecast period.

Nucleotide Market Report Highlights:

The TaqMan allelic discrimination segment dominated the global market in 2024, followed by SNP by pyrosequencing
The diagnostics research segment dominated the global market for nucleotides in 2024
The deoxy nucleotides (dNTPs) segment dominated the global nucleotide market in 2024 with a revenue share of 48.4% and is furthermore likely to expand with the fastest CAGR over the forecast period
North America nucleotide market secured the largest market share of 38.9% in 2024 and Europe nucleotide market is set to expand at the fastest-growing CAGR of 8.4% from 2025 to 2030

Chapter 1. Methodology and Scope

1.1. Market Segmentation & Scope
1.2. Segment Definitions
- 1.2.1. Product
- 1.2.2. Technology
- 1.2.3. Application
1.3. Estimates and Forecast Timeline
1.4. Research Methodology
1.5. Information Procurement
- 1.5.1. Purchased Database
- 1.5.2. GVR's Internal Database
- 1.5.3. Secondary Sources
- 1.5.4. Primary Research
1.6. Information Analysis
- 1.6.1. Data Analysis Models
1.7. Market Formulation & Data Visualization
1.8. Model Details
- 1.8.1. Commodity Flow Analysis
1.9. List of Secondary Sources
1.10. Objectives

Chapter 2. Executive Summary

2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot

Chapter 3. Nucleotide Market Variables, Trends, & Scope

3.1. Market Lineage Outlook
3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
- 3.2.2. Market Restraint Analysis
3.3. Business Environment Analysis
- 3.3.1. Industry Analysis - Porter's Five Forces Analysis
  - 3.3.1.1. Supplier Power
  - 3.3.1.2. Buyer Power
  - 3.3.1.3. Substitution Threat
  - 3.3.1.4. Threat of New Entrant
  - 3.3.1.5. Competitive Rivalry
- 3.3.2. PESTLE Analysis

Chapter 4. Nucleotide Market: Product Business Analysis

4.1. Product Market Share, 2024 & 2030
4.2. Product Segment Dashboard
4.3. Market Size & Forecasts and Trend Analysis, By Product, 2018 to 2030 (USD Million)
4.4. Deoxy Nucleotides
- 4.4.1. Deoxy Nucleotides Market, 2018 - 2030 (USD Million)
  - 4.4.1.1. Enzyme Sourced
    - 4.4.1.1.1. Enzyme Sourced Nucleotides Market, 2018 - 2030 (USD Million)
  - 4.4.1.2. Chemical Synthesis
    - 4.4.1.2.1. Chemical Synthesis Nucleotides Market, 2018 - 2030 (USD Million)
4.5. Dideoxynucleotides
- 4.5.1. Dideoxynucleotides Market, 2018 - 2030 (USD Million)
4.6. Nucleotides for RNA Synthesis (rNTP)
- 4.6.1. Nucleotides for RNA Synthesis (rNTP) Market, 2018 - 2030 (USD Million)
4.7. Labelled Nucleotides
- 4.7.1. Labelled Nucleotides Market, 2018 - 2030 (USD Million)

Chapter 5. Nucleotide Market: Technology Business Analysis

5.1. Technology Market Share, 2024 & 2030
5.2. Technology Segment Dashboard
5.3. Market Size & Forecasts and Trend Analysis, By Technology, 2018 to 2030 (USD Million)
5.4. TaqMan Allelic Discrimination
- 5.4.1. TaqMan Allelic Discrimination Market, 2018 - 2030 (USD Million)
5.5. Gene Chips & Microarrays
- 5.5.1. Gene Chips & Microarrays Market, 2018 - 2030 (USD Million)
5.6. SNP by Pyrosequencing
- 5.6.1. Gene Chips & Microarrays Market, 2018 - 2030 (USD Million)
5.7. Others
- 5.7.1. Others Market, 2018 - 2030 (USD Million)

Chapter 6. Nucleotide Market: Application Business Analysis

6.1. Application Market Share, 2024 & 2030
6.2. Application Segment Dashboard
6.3. Market Size & Forecasts and Trend Analysis, By Application, 2018 to 2030 (USD Million)
6.4. Pharmaceuticals
- 6.4.1. Pharmaceuticals Market, 2018 - 2030 (USD Million)
6.5. Diagnostics Research
- 6.5.1. Diagnostics Research Market, 2018 - 2030 (USD Million)
6.6. Food & Beverage Additive
- 6.6.1. Food & Beverage Additive Market, 2018 - 2030 (USD Million)
6.7. Animal Feed Additive
- 6.7.1. Animal Feed Additive Market, 2018 - 2030 (USD Million)
6.8. Others
- 6.8.1. Others Market, 2018 - 2030 (USD Million)

Chapter 7. Nucleotide Market: Regional Estimates & Trend Analysis

7.1. Regional Market Share Analysis, 2024 & 2030
7.2. Regional Market Dashboard
7.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
7.4. North America
- 7.4.1. North America Nucleotide Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.4.2. U.S.
  - 7.4.2.1. Key Country Dynamic
  - 7.4.2.2. Regulatory Framework
  - 7.4.2.3. Competitive Insights
  - 7.4.2.4. U.S. Nucleotide Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.4.3. Canada
  - 7.4.3.1. Key Country Dynamic
  - 7.4.3.2. Regulatory Framework
  - 7.4.3.3. Competitive Insights
  - 7.4.3.4. Canada Nucleotide Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.4.4. Mexico
  - 7.4.4.1. Key Country Dynamic
  - 7.4.4.2. Regulatory Framework
  - 7.4.4.3. Competitive Insights
  - 7.4.4.4. Mexico Nucleotide Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5. Europe
- 7.5.1. Europe Nucleotide Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.2. UK
  - 7.5.2.1. Key Country Dynamic
  - 7.5.2.2. Regulatory Framework
  - 7.5.2.3. Competitive Insights
  - 7.5.2.4. UK Nucleotide Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.3. Germany
  - 7.5.3.1. Key Country Dynamic
  - 7.5.3.2. Regulatory Framework
  - 7.5.3.3. Competitive Insights
  - 7.5.3.4. Germany Nucleotide Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.4. France
  - 7.5.4.1. Key Country Dynamic
  - 7.5.4.2. Regulatory Framework
  - 7.5.4.3. Competitive Insights
  - 7.5.4.4. France Nucleotide Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.5. Italy
  - 7.5.5.1. Key Country Dynamic
  - 7.5.5.2. Regulatory Framework
  - 7.5.5.3. Competitive Insights
  - 7.5.5.4. Italy Nucleotide Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.6. Spain
  - 7.5.6.1. Key Country Dynamic
  - 7.5.6.2. Regulatory Framework
  - 7.5.6.3. Competitive Insights
  - 7.5.6.4. Spain Nucleotide Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.7. Denmark
  - 7.5.7.1. Key Country Dynamic
  - 7.5.7.2. Regulatory Framework
  - 7.5.7.3. Competitive Insights
  - 7.5.7.4. Denmark Nucleotide Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.8. Sweden
  - 7.5.8.1. Key Country Dynamic
  - 7.5.8.2. Regulatory Framework
  - 7.5.8.3. Competitive Insights
  - 7.5.8.4. Sweden Nucleotide Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.9. Norway
  - 7.5.9.1. Key Country Dynamic
  - 7.5.9.2. Regulatory Framework
  - 7.5.9.3. Competitive Insights
  - 7.5.9.4. Norway Nucleotide Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6. Asia Pacific
- 7.6.1. Asia Pacific Nucleotide Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.6.2. Japan
  - 7.6.2.1. Key Country Dynamic
  - 7.6.2.2. Regulatory Framework
  - 7.6.2.3. Competitive Insights
  - 7.6.2.4. Japan Nucleotide Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.6.3. China
  - 7.6.3.1. Key Country Dynamic
  - 7.6.3.2. Regulatory Framework
  - 7.6.3.3. Competitive Insights
  - 7.6.3.4. China Nucleotide Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.6.4. India
  - 7.6.4.1. Key Country Dynamic
  - 7.6.4.2. Regulatory Framework
  - 7.6.4.3. Competitive Insights
  - 7.6.4.4. India Nucleotide Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.6.5. Australia
  - 7.6.5.1. Key Country Dynamic
  - 7.6.5.2. Regulatory Framework
  - 7.6.5.3. Competitive Insights
  - 7.6.5.4. Australia Nucleotide Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.6.6. Thailand
  - 7.6.6.1. Key Country Dynamic
  - 7.6.6.2. Regulatory Framework
  - 7.6.6.3. Competitive Insights
  - 7.6.6.4. Thailand Nucleotide Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.6.7. South Korea
  - 7.6.7.1. Key Country Dynamic
  - 7.6.7.2. Regulatory Framework
  - 7.6.7.3. Competitive Insights
  - 7.6.7.4. South Korea Nucleotide Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.7. Latin America
- 7.7.1. Latin America Nucleotide Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.7.2. Brazil
  - 7.7.2.1. Key Country Dynamic
  - 7.7.2.2. Regulatory Framework
  - 7.7.2.3. Competitive Insights
  - 7.7.2.4. Brazil Nucleotide Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.7.3. Argentina
  - 7.7.3.1. Key Country Dynamic
  - 7.7.3.2. Regulatory Framework
  - 7.7.3.3. Competitive Insights
  - 7.7.3.4. Argentina Nucleotide Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.8. Middle East and Africa
- 7.8.1. Middle East and Africa Nucleotide Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.8.2. South Africa
  - 7.8.2.1. Key Country Dynamic
  - 7.8.2.2. Regulatory Framework
  - 7.8.2.3. Competitive Insights
  - 7.8.2.4. South Africa Nucleotide Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.8.3. Saudi Arabia
  - 7.8.3.1. Key Country Dynamic
  - 7.8.3.2. Regulatory Framework
  - 7.8.3.3. Competitive Insights
  - 7.8.3.4. Saudi Arabia Nucleotide Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.8.4. UAE
  - 7.8.4.1. Key Country Dynamic
  - 7.8.4.2. Regulatory Framework
  - 7.8.4.3. Competitive Insights
  - 7.8.4.4. UAE Nucleotide Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.8.5. Kuwait
  - 7.8.5.1. Key Country Dynamic
  - 7.8.5.2. Regulatory Framework
  - 7.8.5.3. Competitive Insights
  - 7.8.5.4. Kuwait Nucleotide Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

8.1. Participant Overview
8.2. Company Market Position Analysis
8.3. Company Categorization
8.4. Strategy Mapping
8.5. Company Profiles/Listing
- 8.5.1. CJ CheilJedang Corp.
  - 8.5.1.1. Participant's Overview
  - 8.5.1.2. Financial Performance
  - 8.5.1.3. Product Benchmarking
  - 8.5.1.4. Strategic Initiatives
- 8.5.2. Star Lake Bioscience
  - 8.5.2.1. Participant's Overview
  - 8.5.2.2. Financial Performance
  - 8.5.2.3. Product Benchmarking
  - 8.5.2.4. Strategic Initiatives
- 8.5.3. Thermo Fisher Scientific Inc.
  - 8.5.3.1. Participant's Overview
  - 8.5.3.2. Financial Performance
  - 8.5.3.3. Product Benchmarking
  - 8.5.3.4. Strategic Initiatives
- 8.5.4. MEIHUA HOLDINGS GROUP CO., LTD.
  - 8.5.4.1. Participant's overview
  - 8.5.4.2. Financial Performance
  - 8.5.4.3. Product Benchmarking
  - 8.5.4.4. Strategic Initiatives
- 8.5.5. F. Hoffmann-La Roche Ltd.
  - 8.5.5.1. Participant's Overview
  - 8.5.5.2. Financial Performance
  - 8.5.5.3. Product Benchmarking
  - 8.5.5.4. Strategic Initiatives
- 8.5.6. Biorigin
  - 8.5.6.1. Participant's Overview
  - 8.5.6.2. Financial Performance
  - 8.5.6.3. Product Benchmarking
  - 8.5.6.4. Strategic Initiatives
- 8.5.7. DSM
  - 8.5.7.1. Participant's Overview
  - 8.5.7.2. Financial Performance
  - 8.5.7.3. Product Benchmarking
  - 8.5.7.4. Strategic Initiatives
- 8.5.8. Promega Corporation
  - 8.5.8.1. Participant's Overview
  - 8.5.8.2. Financial Performance
  - 8.5.8.3. Product Benchmarking
  - 8.5.8.4. Strategic Initiatives
- 8.5.9. Agilent Technologies, Inc.
  - 8.5.9.1. Participant's Overview
  - 8.5.9.2. Financial Performance
  - 8.5.9.3. Product Benchmarking
  - 8.5.9.4. Strategic Initiatives
- 8.5.10. Lallemand Inc.
  - 8.5.10.1. Participant's Overview
  - 8.5.10.2. Financial Performance
  - 8.5.10.3. Product Benchmarking
  - 8.5.10.4. Strategic Initiatives
- 8.5.11. Nanjing Biotogether Co., Ltd.
  - 8.5.11.1. Participant's Overview
  - 8.5.11.2. Financial Performance
  - 8.5.11.3. Product Benchmarking
  - 8.5.11.4. Strategic Initiatives
- 8.5.12. NuEra Nutraceuticals Inc.
  - 8.5.12.1. Participant's Overview
  - 8.5.12.2. Financial Performance
  - 8.5.12.3. Product Benchmarking
  - 8.5.12.4. Strategic Initiatives
- 8.5.13. Ohly
  - 8.5.13.1. Participant's Overview
  - 8.5.13.2. Financial Performance
  - 8.5.13.3. Product Benchmarking
  - 8.5.13.4. Strategic Initiatives

簡介目錄圖表

List of Tables

Table 1. List of Secondary Sources
Table 2. List of Abbreviations
Table 3. Global Nucleotide Market, By Region, 2018 - 2030 (USD Million)
Table 4. Global Nucleotide Market, By Product, 2018 - 2030 (USD Million)
Table 5. Global Nucleotide Market, By Technology, 2018 - 2030 (USD Million)
Table 6. Global Nucleotide Market, By Application, 2018 - 2030 (USD Million)
Table 7. North America Nucleotide Market, By Country, 2018 - 2030 (USD Million)
Table 8. North America Nucleotide Market, By Product, 2018 - 2030 (USD Million)
Table 9. North America Nucleotide Market, By Technology, 2018 - 2030 (USD Million)
Table 10. North America Nucleotide Market, By Application, 2018 - 2030 (USD Million)
Table 11. U.S. Nucleotide Market, By Product, 2018 - 2030 (USD Million)
Table 12. U.S. Nucleotide Market, By Technology, 2018 - 2030 (USD Million)
Table 13. U.S. Nucleotide Market, By Application, 2018 - 2030 (USD Million)
Table 14. Canada Nucleotide Market, By Product, 2018 - 2030 (USD Million)
Table 15. Canada Nucleotide Market, By Technology, 2018 - 2030 (USD Million)
Table 16. Canada Nucleotide Market, By Application, 2018 - 2030 (USD Million)
Table 17. Mexico Nucleotide Market, By Product, 2018 - 2030 (USD Million)
Table 18. Mexico Nucleotide Market, By Technology, 2018 - 2030 (USD Million)
Table 19. Mexico Nucleotide Market, By Application, 2018 - 2030 (USD Million)
Table 20. Europe Nucleotide Market, By Country, 2018 - 2030 (USD Million)
Table 21. Europe Nucleotide Market, By Product, 2018 - 2030 (USD Million)
Table 22. Europe Nucleotide Market, By Technology, 2018 - 2030 (USD Million)
Table 23. Europe Nucleotide Market, By Application, 2018 - 2030 (USD Million)
Table 24. UK Nucleotide Market, By Product, 2018 - 2030 (USD Million)
Table 25. UK Nucleotide Market, By Technology, 2018 - 2030 (USD Million)
Table 26. UK Nucleotide Market, By Application, 2018 - 2030 (USD Million)
Table 27. Germany Nucleotide Market, By Product, 2018 - 2030 (USD Million)
Table 28. Germany Nucleotide Market, By Technology, 2018 - 2030 (USD Million)
Table 29. Germany Nucleotide Market, By Application, 2018 - 2030 (USD Million)
Table 30. France Nucleotide Market, By Product, 2018 - 2030 (USD Million)
Table 31. France Nucleotide Market, By Technology, 2018 - 2030 (USD Million)
Table 32. France Nucleotide Market, By Application, 2018 - 2030 (USD Million)
Table 33. Italy Nucleotide Market, By Product, 2018 - 2030 (USD Million)
Table 34. Italy Nucleotide Market, By Technology, 2018 - 2030 (USD Million)
Table 35. Italy Nucleotide Market, By Application, 2018 - 2030 (USD Million)
Table 36. Spain Nucleotide Market, By Product, 2018 - 2030 (USD Million)
Table 37. Spain Nucleotide Market, By Technology, 2018 - 2030 (USD Million)
Table 38. Spain Nucleotide Market, By Application, 2018 - 2030 (USD Million)
Table 39. Denmark Nucleotide Market, By Product, 2018 - 2030 (USD Million)
Table 40. Denmark Nucleotide Market, By Technology, 2018 - 2030 (USD Million)
Table 41. Denmark Nucleotide Market, By Application, 2018 - 2030 (USD Million)
Table 42. Sweden Nucleotide Market, By Product, 2018 - 2030 (USD Million)
Table 43. Sweden Nucleotide Market, By Technology, 2018 - 2030 (USD Million)
Table 44. Sweden Nucleotide Market, By Application, 2018 - 2030 (USD Million)
Table 45. Norway Nucleotide Market, By Product, 2018 - 2030 (USD Million)
Table 46. Norway Nucleotide Market, By Technology, 2018 - 2030 (USD Million)
Table 47. Norway Nucleotide Market, By Application, 2018 - 2030 (USD Million)
Table 48. Asia Pacific Nucleotide Market, By Country, 2018 - 2030 (USD Million)
Table 49. Asia Pacific Nucleotide Market, By Product, 2018 - 2030 (USD Million)
Table 50. Asia Pacific Nucleotide Market, By Technology, 2018 - 2030 (USD Million)
Table 51. Asia Pacific Nucleotide Market, By Application, 2018 - 2030 (USD Million)
Table 52. Japan Nucleotide Market, By Product, 2018 - 2030 (USD Million)
Table 53. Japan Nucleotide Market, By Technology, 2018 - 2030 (USD Million)
Table 54. Japan Nucleotide Market, By Application, 2018 - 2030 (USD Million)
Table 55. China Nucleotide Market, By Product, 2018 - 2030 (USD Million)
Table 56. China Nucleotide Market, By Technology, 2018 - 2030 (USD Million)
Table 57. China Nucleotide Market, By Application, 2018 - 2030 (USD Million)
Table 58. India Nucleotide Market, By Product, 2018 - 2030 (USD Million)
Table 59. India Nucleotide Market, By Technology, 2018 - 2030 (USD Million)
Table 60. India Nucleotide Market, By Application, 2018 - 2030 (USD Million)
Table 61. Australia Nucleotide Market, By Product, 2018 - 2030 (USD Million)
Table 62. Australia Nucleotide Market, By Technology, 2018 - 2030 (USD Million)
Table 63. Australia Nucleotide Market, By Application, 2018 - 2030 (USD Million)
Table 64. Thailand Nucleotide Market, By Product, 2018 - 2030 (USD Million)
Table 65. Thailand Nucleotide Market, By Technology, 2018 - 2030 (USD Million)
Table 66. Thailand Nucleotide Market, By Application, 2018 - 2030 (USD Million)
Table 67. South Korea Nucleotide Market, By Product, 2018 - 2030 (USD Million)
Table 68. South Korea Nucleotide Market, By Technology, 2018 - 2030 (USD Million)
Table 69. South Korea Nucleotide Market, By Application, 2018 - 2030 (USD Million)
Table 70. Latin America Nucleotide Market, By Country, 2018 - 2030 (USD Million)
Table 71. Latin America Nucleotide Market, By Product, 2018 - 2030 (USD Million)
Table 72. Latin America Nucleotide Market, By Technology, 2018 - 2030 (USD Million)
Table 73. Latin America Nucleotide Market, By Application, 2018 - 2030 (USD Million)
Table 74. Brazil Nucleotide Market, By Product, 2018 - 2030 (USD Million)
Table 75. Brazil Nucleotide Market, By Technology, 2018 - 2030 (USD Million)
Table 76. Brazil Nucleotide Market, By Application, 2018 - 2030 (USD Million)
Table 77. Argentina Nucleotide Market, By Product, 2018 - 2030 (USD Million)
Table 78. Argentina Nucleotide Market, By Technology, 2018 - 2030 (USD Million)
Table 79. Argentina Nucleotide Market, By Application, 2018 - 2030 (USD Million)
Table 80. Middle East & Africa Nucleotide Market, By Country, 2018 - 2030 (USD Million)
Table 81. Middle East & Africa Nucleotide Market, By Product, 2018 - 2030 (USD Million)
Table 82. Middle East & Africa Nucleotide Market, By Technology, 2018 - 2030 (USD Million)
Table 83. Middle East & Africa Nucleotide Market, By Application, 2018 - 2030 (USD Million)
Table 84. South Africa Nucleotide Market, By Product, 2018 - 2030 (USD Million)
Table 85. South Africa Nucleotide Market, By Technology, 2018 - 2030 (USD Million)
Table 86. South Africa Nucleotide Market, By Application, 2018 - 2030 (USD Million)
Table 87. Saudi Arabia Nucleotide Market, By Product, 2018 - 2030 (USD Million)
Table 88. Saudi Arabia Nucleotide Market, By Technology, 2018 - 2030 (USD Million)
Table 89. Saudi Arabia Nucleotide Market, By Application, 2018 - 2030 (USD Million)
Table 90. UAE Nucleotide Market, By Product, 2018 - 2030 (USD Million)
Table 91. UAE Nucleotide Market, By Technology, 2018 - 2030 (USD Million)
Table 92. UAE Nucleotide Market, By Application, 2018 - 2030 (USD Million)
Table 93. Kuwait Nucleotide Market, By Product, 2018 - 2030 (USD Million)
Table 94. Kuwait Nucleotide Market, By Technology, 2018 - 2030 (USD Million)
Table 95. Kuwait Nucleotide Market, By Application, 2018 - 2030 (USD Million)